Pharmaceutical Counterfeiting in the US: Differentiating Dimensions of the Risk
Pharmaceutical Counterfeiting in the US: Differentiating Dimensions of the Risk Read the Full Article Justin Heinonen and Jeremy Wilson, 2011 The creation of a product counterfeiting database highlights variation in known incidents of counterfeit pharmaceuticals across several important dimensions. By understanding how these incidents differ, researchers can provide empirical insights into the problem, develop evidence-based …
Pharmaceutical Counterfeiting in the US: Differentiating Dimensions of the Risk Read More »